Document is current

Any future updates will be listed below

Combination therapy involving radiofrequency ablation and targeted chemotherapy with bevacizumab plus paclitaxel and cisplatin in a rabbit VX2 lung tumor model

Crossref DOI link: https://doi.org/10.1186/s13104-018-3358-x

Published Online: 2018-04-24

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark